Search

New MSK research finds adherence is a hurdle for home-based colorectal cancer tests; sheds new light on tumor-associated macrophages in glioblastoma; identifies statins as a promising addition to treatment for HER2-positive gastric cancer; and describes how a new single-cell transcriptome atlas opens the “black box” of early human embryo development.

People with diabetes can face an elevated risk of pancreatic cancer. Two MSK specialists discuss the relationship between diabetes and cancer, put the risk in perspective, and discuss how to manage it.

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that it is ranked among the top 15 organizations with the greatest number of highly cited scientific researchers worldwide, according to the annual list of Highly Cited Researchers published by the Institute for Scientific Information at Clarivate.

Learn how MSK is clarifying how unnecessary medical tests can harm a patient's well-being.

Learn how molecular testing and an experimental targeted therapy cured jazz musician Michael Wolff, who had the rare cancer histiocytic sarcoma.

Seeing Biological Molecules at the Atomic Level: At Work with Christopher Lima, Structural Biology Chair.

Now in its 14th year, Cycle for Survival has raised more than $260 million for research on rare cancers.

Memorial Sloan Kettering plastic and reconstructive surgeon Michelle Coriddi describes breast reconstruction options for women undergoing mastectomy, including implants, flap surgery, TRAM flap, and DIEP flap, and more.